isibhengezo_sekhasi

Imikhiqizo

N,N'-Methylenebisacrylamide Cas: 110-26-9 98% Impushana emhlophe

Incazelo emfushane:

Inombolo Yekhathalogi: XD90231
I-Cas: 110-26-9
I-Molecular Formula: I-C7H10N2O2
Isisindo se-Molecular: 154.1665
Ukutholakala: Kukhona kusitoki
Inani:  
I-Prepack: 100g USD10
Iphakethe lenqwaba: Cela i-Quote

 

 

 

 

 


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Inombolo Yekhathalogi XD90231
Igama Lomkhiqizo N,N'-Methylenebisacrylamide

I-CAS

110-26-9

I-Molecular Formula

I-C7H10N2O2

Isisindo samangqamuzana

154.1665
Imininingwane Yesitoreji 2 kuya ku-8 °C

Ikhodi Yentela Evumelanisiwe

29241900

 

Ukucaciswa Komkhiqizo

Isivivinyo >98%
Amanzi angancibiliki <0.5%
Ukubukeka Impushana emhlophe
Ama-sulfate e-inorganic <0.5%
Okokusetshenziswa kocwaningo kuphela, hhayi okomuntu ukusetshenziswa kocwaningo kuphela, hhayi ukusetshenziswa komuntu

 

Indima ebalulekile ye-tumor-associated fibroblasts (TAF) ekuqhubekeleni phambili komdlavuza manje isicacile kumdlavuza wamaphaphu ongewona omncane (NSCLC).Kodwa-ke, izindlela zokwelapha ezimelene nama-TAF zikhawulelwe ngenxa yokuntula ukuqonda ezindleleni ezithize ze-subtype eziyisisekelo zokunqwabelana kwazo.Lapha, ukuqina komshini (okungukuthi, ukuqina kwe-matrix) kanye nezimpawu ze-mitogenic ezincibilikayo eziqhuba ukunqwabelana kwama-TAF kusuka ezinhlotsheni ezincane ze-NSCLC: i-adenocarcinoma (ADC) kanye ne-squamous cell carcinoma (SCC) zahlakazwa.Ama-fibroblasts akhuliswe ku-substrata eklanyelwe ukukhombisa ukuqina okujwayelekile- noma okufana ne-tumor ekugxilweni okuhlukene kwe-serum, futhi izinqubo zokulawula ezibalulekile zacaciswa.Ekulawuleni ama-fibroblasts asuka kuzicubu ezingenabungozi, ukuqina kwe-matrix kukodwa kukhuphule ukunqwabelana kwe-fibroblast, futhi lo mphumela wokusebenza wawunamandla noma uqhathaniseka nalowo wezici zokukhula ezincibilikayo kufika ku-0.5% serum.Izimpawu ezishukumisayo zokuqina kwe-matrix zaziqhutshwa yi-β1 integrin mechano-sensing nge-FAK (pY397), futhi zazihlotshaniswa nokukhuphuka okuqhutshwa ngemva kokubhala kombhalo ku-β1 integrin expression.Isekethe yokugcina ye-mechano-regulatory nayo yabonwa kuma-TAF kodwa ngendlela ethize ye-subtype, ngoba ama-SCC-TAF abonise i-FAK ephezulu (pY397), i-β1 expression, kanye ne-ERK1/2 (pT202/Y204) kune-ADC-TAFs.Ngaphezu kwalokho, ukuqina kwe-matrix kubangele ukunqwabelana kwe-TAF enkulu kuma-SCC-TAF (>50%) uma kuqhathaniswa nama-ADC-TAF (10% -20%).Ngokuphambene, ama-SCC-TAF ayengazweli kakhulu ku-serum, kuyilapho ama-ADC-TAF asabela ekugxilweni okuphezulu kwe-serum kuphela.Lokhu okutholakele kunikeza ubufakazi bokuqala bokulawulwa kwe-subtype-specific of NSCLC-TAF accumulation.Ngaphezu kwalokho, le datha isekela ukuthi imithi yokwelapha ehloselwe ukubuyisela ukunwebeka okujwayelekile kwamaphaphu kanye/noma ukulawulwa kwe-mechano encike ku-β1 kungase kusebenze ngokumelene nama-SCC-TAFs, kuyilapho ukuvimbela ukusayinda kwesici sokukhula kwe-stromal kungase kusebenze ngokumelene nama-ADC-TAFs.Lolu cwaningo lwembula izindlela ezihlukile eziyisisekelo ukunqwabelana okungavamile kwama-fibroblast asekela isimila ezinhlotsheni ezincane ezimbili ezinkulu zomdlavuza wamaphaphu, okuzosiza ukuthuthukiswa kwezindlela zokwelapha eziqondene nomuntu ngokumelene nalawa maseli.


  • Okwedlule:
  • Olandelayo:

  • Vala

    N,N'-Methylenebisacrylamide Cas: 110-26-9 98% Impushana emhlophe